Nov 1 (Reuters) - Novavax Inc (NVAX.O) expects regulators in India, the Philippines and elsewhere to make a decision on its COVID-19 vaccine within "weeks," its chief executive told Reuters, after the shot on Monday received its first emergency use authorization (EUA) from Indonesia.
...
He said Novavax is “in dialogue with the U.S. FDA and ... we expect a full submission within the next several weeks.”
...
He said Novavax is “in dialogue with the U.S. FDA and ... we expect a full submission within the next several weeks.”

Comment